Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus
Adel Bozorgzadeh, Ashokkumar Jain, Charlotte Ryan, Daniel Ornt, Martin Zand, Parvez Mantry, Kerrie Lansing, Mark Orloff
Dive into the research topics of 'Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus'. Together they form a unique fingerprint.